title: The pleckstrin homology domain of oxysterol-binding protein recognises a determinant specific to Golgi membranes.
abstract: BACKGROUND
  Peripheral membrane proteins are targeted to the cytoplasmic face of specific intracellular membranes. The organelle-specific ligands recognised by peripheral proteins include other proteins and lipids. Oxysterol-binding protein (OSBP) translocates from the cytoplasm to the Golgi apparatus on binding oxygenated derivatives of cholesterol. The mechanism by which OSBP recognises the Golgi is unknown. It does, however, contain a pleckstrin homology (PH) domain, which in other proteins has been found to mediate regulated membrane binding, although in all previously studied examples the binding is to the plasma membrane.
  
  
  RESULTS
  The PH domain of OSBP and of a yeast homologue, Osh1p, were sufficient to target proteins specifically to mammalian Golgi membranes. In addition, high level expression disrupted Golgi architecture and prevented forward traffic of cargo protein. In vitro, the OSBP PH domain bound to Golgi membranes in a manner apparently dependent on phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) or a related phosphatidylinositide. The OSBP PH domain bound to PI(4,5)P2 in liposomes with a submicromolar dissociation constant.
  
  
  CONCLUSIONS
  The PH domains of OSBP and its yeast homologue recognise a determinant which is specific to Golgi membranes and important for Golgi function. The determinant appears to be a combination or a phosphatidylinositol polyphosphate and a second, Golgi-specific feature.
authors.affiliation: MRC Laboratory of Molecular Biology, Cambridge, UK.
authors.forename: T P
authors.initials: TP
authors.lastname: Levine
authors.forename: S
authors.initials: S
authors.lastname: Munro
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001798:Blood Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D020126:Brefeldin A; D017124:Conserved Sequence; D003517:Cyclopentanes / Q000494:pharmacology; D019143:Evolution, Molecular; D005089:Exocytosis; D006056:Golgi Apparatus / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D007425:Intracellular Membranes / Q000737:chemistry / Q000378:metabolism*; D008081:Liposomes / Q000737:chemistry / Q000378:metabolism; D018942:Macrolides; D009183:Mycotoxins / Q000494:pharmacology; D010750:Phosphoproteins; D017434:Protein Structure, Tertiary; D051381:Rats; D011987:Receptors, Steroid / Q000037:antagonists & inhibitors / Q000096:biosynthesis / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D013379:Substrate Specificity; D000098825:Oxysterol Binding Proteins
chemical_list: D000900:Anti-Bacterial Agents; D001798:Blood Proteins; D003517:Cyclopentanes; D008081:Liposomes; D018942:Macrolides; D009183:Mycotoxins; D010750:Phosphoproteins; D011987:Receptors, Steroid; D000098825:Oxysterol Binding Proteins; C039077:platelet protein P47; D020126:Brefeldin A